Clinical Trial Update: PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for mesoCAR-T cells expressing PD-1 antibody targeting mesothelin in advanced solid tumors; status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• PD-1 antibody expressing mesoCAR-T cells (PD-1 antibody expressing mesoCAR-T cells)
• mesoCAR-T cells expressing PD-1 antibody

Snippet

Sponsor: Shanghai Cell Therapy Research Institute | Conditions: Advanced Solid Tumor | Phase 1, Phase 2 | Status: UNKNOWN